🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The trial investigates the efficacy and safety of brodalumab against guselk...
Status
Terminated
Location
LEO Pharma Investigational Site
Start Date
2020-12-17
Trial ID
NCT04533737
Treatments Being Tested
This is a phase 1, multi-center, open-label, drug-drug interaction (DDI) an...
Status
Completed
Location
Research Site
Start Date
2013-09
Trial ID
NCT01937260
Treatments Being Tested
This is an extension study for subjects who participated in Protocol 200900...
Status
Terminated
Location
Research Site
Start Date
2010-06-03
Trial ID
NCT01059448
Treatments Being Tested
This is a randomized, placebo-controlled, ascending single dose study of KH...
Status
Completed
Location
Multiple Locations
Start Date
2011-11
Trial ID
NCT01488201
A healthy subject, 2-way cross-over study to evaluate the bioequivalence of...
Status
Completed
Location
Research Site
Start Date
2014-09
Trial ID
NCT02173392
Treatments Being Tested
To evaluate the efficacy and safety of KHK4827 in patients with systemic sc...
Status
Completed
Location
Chukyo Hospital
Start Date
2019-05-23
Trial ID
NCT03957681
The purpose of this study is to assess the safety and efficacy of brodaluma...
Status
Terminated
Location
Research Site
Start Date
2012-08
Trial ID
NCT01708590
Treatments Being Tested
An Open-label, Single-dose Study to Evaluate Safety, Tolerability, and Phar...
Status
Active Not Recruiting
Location
Bausch Site 003
Start Date
2020-01-24
Trial ID
NCT03240809
Treatments Being Tested
The purpose of this study is to further evaluate the safety of infliximab, ...
Status
Active Not Recruiting
Location
Multiple Locations
Start Date
2007-06-21
Trial ID
NCT00508547
This study is designed to evaluate safety and efficacy of long-term exposur...
Status
Completed
Location
For additional information regarding investigative sites for this trial, contact Kyowa Hakko Kirin
Start Date
2013-03
Trial ID
NCT01782924
Treatments Being Tested